Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Drug-resistant tuberculosis in high-risk groups, Zimbabwe

Emerging Infectious Diseases, Volume 20, No. 1, Year 2014

To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smearpositive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.

Metcalfe, John Z.
1. United States, San Francisco San Francisco General Hospital and Trauma Center
Makumbirofa, Salome
1. Zimbabwe, Harare Biomedical Research and Training Institute Harare
Makamure, Beauty
1. Zimbabwe, Harare Biomedical Research and Training Institute Harare
Sandy, Charles
1. Unknown Affiliation
Bara, Wilbert
1. Zimbabwe, Harare Harare City Health Department
Mungofa, Stanley
1. Zimbabwe, Harare Harare City Health Department
Hopewell, Philip C.
1. United States, San Francisco San Francisco General Hospital and Trauma Center
Mason, Peter R.
1. Zimbabwe, Harare Biomedical Research and Training Institute Harare
2. Zimbabwe, Harare University of Zimbabwe

AFRICAN RESEARCH NEXUS

Drug-resistant tuberculosis in high-risk groups, Zimbabwe

Disclaimer

African Research Nexus

Useful Links

AFRICAN RESEARCH NEXUS

Drug-resistant tuberculosis in high-risk groups, Zimbabwe

Description

Authors & Co-Authors

Disclaimer

African Research Nexus

Useful Links